Across TCGA pan-cancer cohorts, ZNF731P RNA is linked to patient survival in 27 of 34 cancer types, making it the most broadly survival-associated ZNF731P data layer.
The strongest signal is observed in adrenocortical carcinoma (ACC), where higher ZNF731P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated ZNF731P expression acts as an unfavorable survival marker, although some lineages such as BLCA and HNSC show a favorable association.
ACC, BLCA, and HNSC are the cancer types where ZNF731P RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.